Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Peginterferon alpha
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ViraferonPeg 100microgram inj pre-filled pens
0802040A0BBAIAK
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 100microgram inj pre-filled pens CLEARCLICK
0802040A0BBAPAK
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 100microgram inj vials
0802040A0BBABAB
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 120microgram inj pre-filled pens
0802040A0BBAGAI
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 120microgram inj pre-filled pens CLEARCLICK
0802040A0BBAMAI
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 120microgram inj vials
0802040A0BBAEAE
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj pre-filled pens
0802040A0BBAFAH
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj pre-filled pens CLEARCLICK
0802040A0BBANAH
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj vials
0802040A0BBADAD
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens
0802040A0BBAHAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens CLEARCLICK
0802040A0BBALAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj vials
0802040A0BBACAC
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens
0802040A0BBAJAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens CLEARCLICK
0802040A0BBAKAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj vials
0802040A0BBAAAA
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.